Search Results - "Burkart C"

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Dual-phase multidetector thin-section CT in detecting duodenal gastrinoma.

Authors: Pfannenberg, A. C. Burkart, C. Kröber, S. M. et al.

Source: Abdominal Imaging. Sep/Oct2005, Vol. 30 Issue 5, p543-547. 5p. 4 Black and White Photographs.

This result is not displayed to guests.
Login for full access.

Contribution of increased ISG15, ISGylation and deregulated type I IFN signaling in Usp18 mutant mice during the course of bacterial infections.

Authors: Dauphinee, S M Richer, E Eva, M M et al.

Source: Genes & Immunity. Jul/Aug2014, Vol. 15 Issue 5, p282-292. 11p.

Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial.

Authors: Huebner, G. Link, H. Kohne, C. H. et al.

Source: British Journal of Cancer. 1/13/2009, Vol. 100 Issue 1, p44-49. 6p. 1 Diagram, 3 Charts, 2 Graphs.

1624P Predictive factors for treatment success of second-line Nal-IRI/5-FU/FA in patients with metastatic pancreatic ductal adenocarcinoma (PDAC) (AIO-PAK-0216).

Authors: Lutz, M.P. Ansorge, N. Barmashenko, G. et al.

Source: Annals of Oncology. 2023 Supplement 2, Vol. 34, pS899-S900. 2p.

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

Authors: Oettle H Post S Neuhaus P et al.

Source: JAMA: Journal of the American Medical Association. 1/17/2007, Vol. 297 Issue 3, p267-277. 11p.

Chelation therapy for ischemic heart disease: a randomized controlled trial.

Authors: Knudtson ML Wyse DG Galbraith PD et al.

Source: JAMA: Journal of the American Medical Association. 1/23/2002, Vol. 287 Issue 4, p481-528. 8p.

URL: 5921738

A human histidyl-tRNA synthetase splice variant therapeutic targets NRP2 to resolve lung inflammation and fibrosis.

Authors: Nangle LA Xu Z Siefker D et al.

Source: Science translational medicine [Sci Transl Med] 2025 Mar 12; Vol. 17 (789), pp. eadp4754. Date of Electronic Publication: 2025 Mar 12.

Publication Type: Journal Article

Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer-results from the FIRE-4.5 study.

Authors: Klein-Scory S Baraniskin A Schmiegel W et al.

Source: Molecular oncology [Mol Oncol] 2025 Feb; Vol. 19 (2), pp. 344-356. Date of Electronic Publication: 2024 Dec 04.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

Predictive criteria for overall survival and treatment duration of 2nd-line chemotherapy in patients with advanced pancreatic adenocarcinoma (AIO-PAK-0216).

Authors: Lutz MP Ansorge N Barmashenko G et al.

Source: British journal of cancer [Br J Cancer] 2026 Jan; Vol. 134 (1), pp. 85-91. Date of Electronic Publication: 2025 Oct 14.

Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study

Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer.

Authors: Xu Z Goel HL Burkart C et al.

Source: Science translational medicine [Sci Transl Med] 2023 May 03; Vol. 15 (694), pp. eadf1128. Date of Electronic Publication: 2023 May 03.

Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural

Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

Societal Roles of Nonprofit Organizations: Parsonian Echoes and Luhmannian Reframing of the Organization-Society Interface.

Authors: Maier F Meyer M Burkart C et al.

Source: Nonprofit and voluntary sector quarterly [Nonprofit Volunt Sect Q] 2025 Apr; Vol. 54 (2), pp. 327-349. Date of Electronic Publication: 2024 Apr 11.

Publication Type: Journal Article

Journal Info: Publisher: Jossey-Bass Country of Publication: United States NLM ID: 9886050 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0899-7640 (Print) Linking ISSN: 08997640 NLM ISO Abbreviation: Nonprofit Volunt Sect Q Subsets: PubMed not MEDLINE

Corrigendum to "mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214) and the ABCSG (R-06)": [ESMO Open 9 (2024) 103703].

Authors: Hofheinz RD Herrle F Dechow T et al.

Source: ESMO open [ESMO Open] 2025 Feb; Vol. 10 (2), pp. 104095. Date of Electronic Publication: 2024 Dec 16.

Publication Type: Published Erratum

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE; PubMed not MEDLINE

mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214).

Authors: Hofheinz RD Herrle F Dechow T et al.

Source: ESMO open [ESMO Open] 2024 Sep; Vol. 9 (9), pp. 103703. Date of Electronic Publication: 2024 Sep 10.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Development and Characterization of a Novel Neuropilin-2 Antibody for Immunohistochemical Staining of Cancer and Sarcoidosis Tissue Samples.

Authors: Förster S Chong YE Siefker D et al.

Source: Monoclonal antibodies in immunodiagnosis and immunotherapy [Monoclon Antib Immunodiagn Immunother] 2023 Oct; Vol. 42 (5), pp. 157-165.

Publication Type: Journal Article

Journal Info: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101590955 Publication Model: Print Cited Medium: Internet ISSN: 2167-9436 (Electronic) Linking ISSN: 21679436 NLM ISO Abbreviation: Monoclon Antib Immunodiagn Immunother Subsets: MEDLINE

FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAF^V600E-Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study.

Authors: Stintzing S Heinrich K Tougeron D et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Sep 01; Vol. 41 (25), pp. 4143-4153. Date of Electronic Publication: 2023 Jun 23.

Publication Type: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Efzofitimod: a novel anti-inflammatory agent for sarcoidosis.

Authors: Baughman RP Niranjan V Walker G et al.

Source: Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG [Sarcoidosis Vasc Diffuse Lung Dis] 2023 Mar 28; Vol. 40 (1), pp. e2023011. Date of Electronic Publication: 2023 Mar 28.

Publication Type: Journal Article

Journal Info: Publisher: Mattioli 1885 Country of Publication: Italy NLM ID: 9610928 Publication Model: Electronic Cited Medium: Internet ISSN: 2532-179X (Electronic) Linking ISSN: 11240490 NLM ISO Abbreviation: Sarcoidosis Vasc Diffuse Lung Dis Subsets: PubMed not MEDLINE

Usp18 deficient mammary epithelial cells create an antitumour environment driven by hypersensitivity to IFN-λ and elevated secretion of Cxcl10.

Authors: Burkart C Arimoto K Tang T et al.

Source: EMBO molecular medicine [EMBO Mol Med] 2013 Jul; Vol. 5 (7), pp. 1035-50. Date of Electronic Publication: 2013 May 16.

Publication Type: Journal Article; Research Support, N.I.H., Extramural

Journal Info: Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE